<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Med Litu</journal-id><journal-id journal-id-type="iso-abbrev">Acta Med Litu</journal-id><journal-id journal-id-type="publisher-id">AML</journal-id><journal-title-group><journal-title>Acta Medica Lituanica</journal-title></journal-title-group><issn pub-type="ppub">1392-0138</issn><issn pub-type="epub">2029-4174</issn><publisher><publisher-name>Lithuanian Academy of Sciences Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29928154</article-id><article-id pub-id-type="pmc">PMC6007999</article-id><article-id pub-id-type="doi">10.6001/actamedica.v25i1.3700</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Primary gastric Burkitt lymphoma-induced anaemia: a case report and a literature review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kapitan&#x0010d;uk&#x00117;</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Va&#x00161;&#x0010d;i&#x0016b;nait&#x00117;</surname><given-names>Agnija</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Augustinien&#x00117;</surname><given-names>Rasa</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sakalinskien&#x00117;</surname><given-names>J&#x0016b;rat&#x00117;</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kleinotien&#x00117;</surname><given-names>Gra&#x0017e;ina</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><sup>1</sup> Faculty of Medicine, Vilnius University, Vilnius, Lithuania</aff><aff id="aff2"><sup>2</sup> Department of Radiology, Children&#x02019;s Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania</aff><aff id="aff3"><sup>3</sup>Centre of Surgery, Subdivision of Endoscopy, Children&#x02019;s Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania</aff><author-notes><corresp id="cor1">Monika Kapitan&#x0010d;uk&#x00117;, Children&#x02019;s Hospital, Vilnius University Hospital Santaros Klinikos, Santari&#x00161;ki&#x00173; St. 4, Vilnius 08406, Lithuania. Email: <email>kapitancuke.m@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><year>2018</year></pub-date><volume>25</volume><issue>1</issue><fpage>23</fpage><lpage>30</lpage><history><date date-type="received"><day>22</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; Lietuvos moksl&#x00173; akademija, 2018</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract><sec><title>Background.</title><p>Primary tumours of the gastrointestinal tract are very uncommon in children. They can present with anaemia caused by gastrointestinal acute or chronic bleeding. One of the most common gastrointestinal tumours is Burkitt lymphoma. This lymphoma is a highly aggressive, rapidly growing B-cell neoplasm, making survival without treatment possible only for a few weeks. For this reason it requires immediate hospitalization and treatment.</p></sec><sec><title>Case report.</title><p>We report a case of a gastric Burkitt lymphoma in an adolescent girl who presented with anaemia due to gastrointestinal bleeding. She received out-patient care with iron medications orally due to suspected iron-deficiency anaemia but there was no sufficient effect. The patient was referred to Children&#x02019;s Oncohematology Department with a progression of symptoms (weakness, fatigue, sound in the ears, and nausea) five months after anaemia was diagnosed in the complete blood count. The imaging tests showed a massive solid tumour with bleeding in the stomach. The final diagnosis was a histologically atypical Burkitt lymphoma. Chemotherapy treatment was started according to NHL-BFM 2004 paediatric protocol.</p></sec><sec><title>Conclusions.</title><p>Non-Hodgin&#x02019;s lymphoma is the most common malignancy of the gastrointestinal tract in children and about 75% of these tumours are Burkitt lymphomas. They can present with anaemia in the complete blood count due to bleeding. Reticulocyte test and serum ferritin level test help to differentiate pathophysiological origin of anaemia. Combination chemotherapy according to standardized protocols is the best current standard of care and has a very good clinical response without unfavourable risk factors.</p></sec></abstract><trans-abstract xml:lang="lt"><sec id="sec5"><title>PIRMIN&#x00116;S SKRAND&#x0017d;IO BERKITO (BURKITT) LIMFOMOS SUKELTA ANEMIJA: KLINIKINIO ATVEJO PRISTATYMAS IR LITERAT&#x0016a;ROS AP&#x0017d;VALGA</title><p>Santrauka</p><p><bold>&#x0012e;vadas.</bold> Pirminiai piktybiniai vir&#x00161;kinamojo trakto navikai yra labai retas vaik&#x00173; susirgimas. Piktybinis procesas gali pasireik&#x00161;ti anemija, kuri&#x00105; sukelia l&#x00117;tinis ar &#x0016b;minis kraujavimas i&#x00161; vir&#x00161;kinamojo trakto. Vienas i&#x00161; da&#x0017e;niausi&#x00173; vir&#x00161;kinamojo trakto navik&#x00173; yra Berkito limfoma. &#x00160;i limfoma labai agresyvi, greitai auga B-l&#x00105;steli&#x00173; neoplazma, negydant i&#x00161;gyvenamumo trukm&#x00117; tik kelios savait&#x00117;s, tod&#x00117;l reikalinga greita hospitalizacija ir gydymas.</p><p><bold>Klininkinis avejis.</bold> Pristatome klinikin&#x0012f; paaugl&#x00117;s atvej&#x0012f;, kuri atvyko d&#x00117;l anemijos, sukeltos kraujavimo i&#x00161; vir&#x00161;kinamojo trakto. &#x0012e;tariant gele&#x0017e;ies stokos ma&#x0017e;akraujyst&#x00119;, pacient&#x00117; ambulatori&#x00161;kai gydyta peroraliniais gele&#x0017e;ies preparatais, ta&#x0010d;iau pakankamo efekto negauta. Po penki&#x00173; m&#x00117;nesi&#x00173;, kai bendrame kraujo tyrime buvo nustatyta anemija, mergina pateko &#x0012f; vaik&#x00173; onkohematologijos skyri&#x00173; d&#x00117;l progresuojan&#x0010d;i&#x00173; klinikini&#x00173; simptom&#x00173; (silpnumo, nuovargio, &#x0016b;&#x0017e;esio ausyse ir pykinimo). Vaizdiniuose tyrimuose skrandyje buvo matomas didelis kraujuojantis solidinis navikas. Histologi&#x00161;kai patvirtinta atipin&#x00117; Berkito limfoma. Prad&#x00117;tas chemoterapinis gydymas, remiantis Europoje standartizuotu vaik&#x00173; B-NHL BFM 2004 protokolu.</p><p><bold>I&#x00161;vados.</bold> Ne-Hod&#x0017e;kino limfoma yra da&#x0017e;niausiai nustatomas piktybinis vir&#x00161;kinamojo trakto navikas vaikams, 75 % atvej&#x00173; histologi&#x00161;kai patvirtinama Berkito limfoma. &#x00160;i limfoma d&#x00117;l kraujavimo gali sukelti anemij&#x00105;. Patofiziologin&#x00119; anemijos kilm&#x00119; padeda diferencijuoti bendras kraujo tyrimas su retikuliocit&#x00173; skai&#x0010d;iumi ir serumo feritino kiekio nustatymas. Geriausias gydymo standartas yra polichemoterapija, taikoma pagal Europoje standartizuot&#x00105; vaik&#x00173; B-NHL BFM 2004 protokol&#x00105;. Nesant prognosti&#x00161;kai nepalanki&#x00173; veiksni&#x00173; pasiekiamas labai geras atsakas.</p><p><bold>Rakta&#x0017e;od&#x0017e;iai:</bold> vir&#x00161;kinimo traktas, Berkito limfoma, paauglys, anemija, kraujavimas</p></sec></trans-abstract><kwd-group kwd-group-type="author"><kwd>gastrointestinal</kwd><kwd>Burkitt lymphoma</kwd><kwd>adolescent</kwd><kwd>anaemia</kwd><kwd>bleeding</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>INTRODUCTION</title><p>Burkitt lymphoma (BL) is a highly aggressive, rapidly growing B-cell neoplasm that is characterized by dysregulation of the C-MYC oncogene (<xref rid="ref1" ref-type="bibr">1</xref>). This subtype of non-Hodgkin lymphoma (NHL) generally involves the abdomen as a primary site of presentation (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref3" ref-type="bibr">3</xref>). Burkitt lymphoma can occur in all parts of the gastrointestinal tract (GI) from the stomach to the rectum, but the most frequent location is small and large intestines (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>). Overall, BL is the most common subtype of primary tumours of GI tract. However, the actual incidence in the paediatric population is unknown due to low prevalence (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref6" ref-type="bibr">6</xref>). Patients with BL often complain of abdominal pain (<xref rid="ref1" ref-type="bibr">1</xref>). It can also present with anaemia caused by acute or chronic gastrointestinal bleeding (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref6" ref-type="bibr">6</xref>).</p><p>We report an extremely rare case of an adolescent female diagnosed with Burkitt lymphoma located in the stomach. The first symptom of this disease was anaemia in the complete blood count. An informed written consent was obtained from the patient for inclusion in the present study.</p></sec><sec id="sec2"><title>CLINICAL CASE</title><p>A 15-year-old female, who presented with a oneweek history of weakness and fatigue, was consulted by a family physician. The full blood count showed anaemia with haemoglobin (Hb) 80 g/l (mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) were unknown). The physician suspected iron-deficiency anaemia and prescribed iron medication orally. During the one-month treatment period, haemoglobin increased to 90 g/l with regression of symptoms. Five months after anaemia was diagnosed in the full blood count, the patient was admitted to Children&#x02019;s Oncohematology Department. Upon presentation to the department, clinical symptoms were progressing again for four days, with greater weakness, fatigue, sound in the ears, and nausea. She had not had complaints related to gastrointestinal system disorders; the last menstruations were not abundant and regular; her family history was negative for gastrointestinal malignancies. Moreover, the parents pointed out that the girl was on a diet with a limited amount of meat and with plenty of physical activity. On physical examination, the patient presented with pale skin and mucosa, tachycardia (144 beats per minute), and harsh systolic murmur. There was no respiratory distress, lymphadenopathy, abdominal pain and masses, hepatosplenomegaly, and no melena. The laboratory tests showed severe normocytic hypochromic anaemia (Hb 44 g/l, MCV 76.2 fl, MCH 20.6 pg, MCHC 270 g/l), erythrocytopenia (2.14 &#x000d7; 10<sup>12/l</sup>), low hematocrit level (16.3%), reticulocytosis (5.13%), and an elevated platelet count (543 &#x000d7; 10<sup>9/l</sup>). The peripheral blood smear revealed no immature cells. Biochemical analysis showed a normal ferritin level (12.38 mkg/l) and normal results of coagulation. Occult blood was positive in the stool. At ultrasound examination, the left subcostal view showed an empty stomach with an unevenly thickened wall (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). A closer look revealed a polymorphic tumour with hypoechogenic, nodal architecture (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). The tumour emerged from the wall of the antrum and pylorus, and measured 120 &#x000d7; 102 &#x000d7; 86 mm. Gas foci, probably originating from the compressed stomach, were seen inside. The tumour revealed active blood flow (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). Lymphadenopathy was observed in the surrounding mesenteric fat. The tumour mass was located adjacent to the pancreas, the spleen, and the left liver lobe. We found neither evidence of invasion of the pancreas nor liver metastasis.</p><p>An esophagogastroduodenoscopy (EDG), which was performed under general anaesthesia, showed a massive solid tumour in the gastric antrum and pylorus with ulceration and protrusion into the gastric lumen (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). Multiple biopsies of the tumour were obtained. Immunohistochemistry revealed that neoplasm cells were positive for CD10, Bcl6, c-MYC (8q24 translocation) and negative for MUM1, TdT and Bcl2, Ki67 proliferative index higher than 95%. The final diagnosis was atypical Burkitt lymphoma. Magnetic resonance imaging (MRI) of the abdomen showed a large mass originating from the gastric wall but not infiltrating the surrounding organs, approximately 13.0 &#x000d7; 5.0 &#x000d7; 11.0 cm, with a pathologic left para-aortic lymph node. The computed tomography (CT) of the chest did not indicate any lymph node involvement or distant metastasis. Bone marrow aspirate and cerebrospinal fluid were negative for lymphoma. Based on the results of the examinations, the patient was graded as a second risk group (R2) since lactate dehydrogenase (LDH) levels were normal 217 U/l. The treatment was started according to the paediatric NHL-BFM 2004 protocol. She went on to receive four chemotherapy blocks. After the second chemotherapy block, a follow-up EGD showed tumour involution and scarification in the gastric wall (<xref ref-type="fig" rid="fig5">Fig. 5</xref>).</p><fig-group orientation="portrait" id="d35e235" position="float"><fig id="fig1" orientation="portrait" position="anchor"><label>Fig. 1.</label><caption><p>Axial sonogram of the upper abdomen. A mass (arrows) is emerging from the stomach wall. Gas foci can be seen inside the tumour</p></caption><graphic xlink:href="aml-25-023-g001"/></fig><fig id="fig2" orientation="portrait" position="anchor"><label>Fig. 2.</label><caption><p>Sagittal (A) and axial (B) sonograms of the upper abdomen. The mass is heterogeneous, nodular elements</p></caption><graphic xlink:href="aml-25-023-g002"/></fig><fig id="fig3" orientation="portrait" position="anchor"><label>Fig. 3.</label><caption><p>Oblique B-mode (A) and power Doppler (B) views of the mass. Active blood flow</p></caption><graphic xlink:href="aml-25-023-g003"/></fig><fig id="fig4" orientation="portrait" position="anchor"><label>Fig. 4.</label><caption><p>Esophagogastroduodenoscopy revealed a massive solid tumour in gastric antrum and pylorus with ulceration and protrusion into the gastric lumen</p></caption><graphic xlink:href="aml-25-023-g004"/></fig><fig id="fig5" orientation="portrait" position="anchor"><label>Fig. 5.</label><caption><p>Esophagogastroduodenoscopy showed tumour involution and scarification in the gastric wall after the second chemotherapy block</p></caption><graphic xlink:href="aml-25-023-g005"/></fig></fig-group></sec><sec sec-type="discussion" id="sec3"><title>DISCUSSION</title><p>Non-Hodgin lymphoma is the most common alimentary tract malignancy in children and comprises 74% of all GI cases. The most frequent histological subtype of these tumours is Burkitt lymphoma, which accounts for up to 75% of the lesions (<xref rid="ref6" ref-type="bibr">6</xref>). In paediatric population, Burkitt lymphoma most commonly involves small intestine and the second &#x02013; large intestine (<xref rid="ref4" ref-type="bibr">4</xref>). However, this lymphoma rarely develops in the stomach; therefore the majority of the available literature describes single case reports. One large retrospective series on abdominal Burkitt lymphoma in children, published by Alireza Mirshemirani et al. in 2016, identified 17 cases (37%) from 46 patients with BL in small intestine and only two cases (4%) in the stomach (<xref rid="ref1" ref-type="bibr">1</xref>).</p><p>Comparing paediatric and adults studies, Burkitt lymphoma is a very rare variant of gastric lymphomas in adults as well. The most common types of gastric lymphomas in adult population are diffuse large B-cell lymphoma (DLBCL) and marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) (<xref rid="ref7" ref-type="bibr">7</xref>, <xref rid="ref8" ref-type="bibr">8</xref>). In one large study, 61 primary lymphomas of the GI tract were diagnosed in Clinical County Emergency Hospital of Romania from 2010 to 2016. Thirty-four of these cases were in the stomach. According to the histological type, 25 of the 34 gastric lymphomas (73.53%) were diagnosed as DLBCL, six as MALT lymphomas (17.65%), two as B-cell lymphomas-not otherwise specified (5.88%), and only in one case (2.94%) Burkitt lymphoma was identified (<xref rid="ref9" ref-type="bibr">9</xref>). For adults, MALT lymphoma is associated with <italic>Helicobacter pylori</italic> infection in the stomach (<xref rid="ref10" ref-type="bibr">10</xref>).</p><p>MALT lymphoma in children population is extremely rare: only a few cases are found in the literature. Also, the relationship between NHL and <italic>H. pylori</italic> in paediatric population is controversial. One single study revealed that two cases of gastric BL were related with <italic>H. pylori</italic> infection (<xref rid="ref11" ref-type="bibr">11</xref>). Results of another study suggested that <italic>H. pylori</italic> may not be the responsible agent for NHL in the abdomen in childhood (<xref rid="ref12" ref-type="bibr">12</xref>).</p><p>The peak age for Burkitt lymphoma in children is 5&#x02013;15 years, with more cases in boys than in girls (3.9:1.1) (<xref rid="ref13" ref-type="bibr">13</xref>). BL is characterized by dysregulation of the c-MYC oncogene (<xref rid="ref13" ref-type="bibr">13</xref>). Deregulation of c-MYC prevents B-cell differentiation and has oncogenic activity (<xref rid="ref6" ref-type="bibr">6</xref>). Cytogenetic evidence of c-MYC rearrangement is the gold standard for the diagnosis of BL (<xref rid="ref14" ref-type="bibr">14</xref>). Three major clinical types of Burkitt lymphoma exist: (<xref rid="ref1" ref-type="bibr">1</xref>) the endemic form, which is a common childhood malignancy strongly associated with the Epstein-Barr virus (EBV), (<xref rid="ref2" ref-type="bibr">2</xref>) the non-endemic (sporadic) form which is rare, and (<xref rid="ref3" ref-type="bibr">3</xref>) immunodeficiency-related BL, mostly seen in AIDS patients. The sporadic form typically presents itself as extranodal disease. The clinical manifestation is related to the location of the primary tumour. According to various studies, the most common presentation of primary abdominal Burkitt lymphoma is reported to be abdominal pain (85%), followed by abdominal swelling, vomiting, constipation, diarrhoea, melena, and rectal bleeding (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref5" ref-type="bibr">5</xref>). Symptoms can present themselves urgently with an acute exacerbation caused by intussusception, appendicitis, perforation, or bowel obstruction (<xref rid="ref6" ref-type="bibr">6</xref>). About 14% of Burkitt lymphoma tumours can arise in the bone marrow. This variety is called Burkitt cell leukemia (<xref rid="ref3" ref-type="bibr">3</xref>). CNS involvement is diagnosed in 8.8% of patients with Burkitt lymphoma/leukemia (<xref rid="ref13" ref-type="bibr">13</xref>).</p><p>The stage of the disease in children in NHL is usually determined according to the St. Jude staging system modified by Murphy. In this staging classification, primary localized gastrointestinal tumour is identified as stage II. The German Berlin-Frankfurt-Munster (BFM) protocol distinguishes four therapy risk groups (R1-R4) based on the stage of the disease, resectability, the amount of LDH and CNS, or bone marrow involvement (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref13" ref-type="bibr">13</xref>). The diagnosis of Burkitt lymphoma and its stage are confirmed by histological and imaging findings (<xref rid="ref15" ref-type="bibr">15</xref>). However, these diagnostic methods come with a number of distinct challenges in paediatric population. Esophagogastroduodenoscopy in children almost always needs to be performed under anaesthesia. In our case report, esophagogastroduodenoscopy under general anesthesia was done on the second day after abdominal ultrasound findings.</p><p>The main treatment is combination chemotherapy according to the B-NHL BFM 2004 protocol (<xref rid="ref13" ref-type="bibr">13</xref>). Considerable progress has been achieved, with survival rates exceeding 80%, largely because of a better understanding of the biology of the different subtypes and national and international collaborations (<xref rid="ref16" ref-type="bibr">16</xref>). Burkitt lymphoma usually has good clinical response to chemotherapy treatment. In several clinical reports, the 5-year eventfree survival (EFS) is about 82&#x02013;88% in adolescent and children respectively. The 3-year EFS is more than 95% for R1 and R2 group patients, 93% for R3 and R4 group patients, and 70% in patients with CNS disease at presentation according to paediatric NHL-BFM-95 protocol (<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref17" ref-type="bibr">17</xref>). Between July 1989 and March 2007, relapses were studied in the LMB89, 96 and 2001 studies of the French Society of Paediatric Oncology (Soci&#x000e9;t&#x000e9; Fran&#x000e7;aise des Cancers de l&#x02019;Enfant). Of 1322 patients, 67 (5%) relapsed: 57 had Burkitt lymphoma and ten had large-cell histology. Relapse was associated with the increase of lactate dehydrogenase (LDH) level to double the normal level, and CNS and/or bone marrow involvement (<xref rid="ref18" ref-type="bibr">18</xref>).</p><p>In the literature, the second most common gastrointestinal tumour of childhood is carcinoma (<xref rid="ref4" ref-type="bibr">4</xref>). However, in most cases of gastric Burkitt lymphoma need to be differentiated with gastrointestinal stromal tumour (GIST). GIST is found in the stomach in about 60% of cases. The macroscopic view is similar to the one that was found in our patient during endoscopic investigation: solid, white or rosy, commonly ulceral, hemorrhagic surface with cystic degeneration and necrosis (<xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>). There is female predominance and the median age of diagnosis is 14 years. Kaemmer and colleagues documented 59 patients from 106 published articles and 86% of them presented with anaemia (acute and/or chronic), melena, hematemesis, pallor, fatigue, or syncope (<xref rid="ref20" ref-type="bibr">20</xref>). GIST is diagnosed on the basis of the morphology and immunohistochemical findings (<xref rid="ref21" ref-type="bibr">21</xref>). The 3-year EFS of GIST is lower compared to Burkitt lymphoma (<xref rid="ref22" ref-type="bibr">22</xref>).</p><p>Differential diagnosis of anaemia helps to identify the origin of anaemia. Iron deficiency anaemia is a type of microcytic hypochromic anaemia with decreased or normal levels of reticulocytes and decreased serum ferritin level (<xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref24" ref-type="bibr">24</xref>). After acute bleeding the most typical view is reticulocytosis and normocytic hypochromic anaemia (<xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref24" ref-type="bibr">24</xref>). In addition, the reticulocyte count can increase in post hemolytic anaemia and in response to therapies such as iron supplementation (<xref rid="ref25" ref-type="bibr">25</xref>). Comparing acute and chronic post hemorrhagic anaemia, chronic anaemia attributes of iron deficiency view in laboratory tests (<xref rid="ref24" ref-type="bibr">24</xref>). Our patient&#x02019;s laboratory tests showed severe normocytic hypochromic anaemia with reticulocytosis and a normal serum ferritin level. These results helped in rejecting iron deficiency anaemia and rapidly finding the source of bleeding.</p></sec><sec sec-type="conclusions" id="sec4"><title>CONCLUSIONS</title><p>Primary gastrointestinal tumours in children are rare. Non-Hodgin lymphoma remains the most common malignancy of the gastrointestinal tract in children. In most cases the histologic subtype of these tumours is Burkitt lymphoma. It can present with anaemia caused by gastrointestinal acute or chronic bleeding. Complete blood count with reticulocyte test and ferritin level helps to differentiate pathophysiology of anaemia. Burkitt lymphoma is a highly aggressive, rapidly growing neoplasm. However, if treatment is started in time and there is no unfavorable risk factors, the good clinical response with 3-years EFS is more than 95%. Combination chemotherapy according to standardized protocols is the best current standard of care.</p><p><bold>Monika Kapitan&#x0010d;uk&#x00117;, Agnija Va&#x00161;&#x0010d;i&#x0016b;nait&#x00117;, Rasa Augustinien&#x00117;, J&#x0016b;rat&#x00117; Sakalinskien&#x00117;, Gra&#x0017e;ina Kleinotien&#x00117;</bold></p></sec></body><back><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoroubi</surname><given-names>J</given-names></name><name name-style="western"><surname>Mirshemirani</surname><given-names>A</given-names></name><name name-style="western"><surname>Kouranloo</surname><given-names>J</given-names></name><name name-style="western"><surname>Nazari</surname><given-names>S</given-names></name></person-group>
<article-title>Abdominal Burkitt&#x02019;s lymphoma in children</article-title>. <source>Iranian Journal of Pediatric Surgery</source>. <year>2015</year>; <volume>1</volume>(<issue>1</issue>): <fpage>28</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosolen</surname><given-names>A</given-names></name><name name-style="western"><surname>Mussolin</surname><given-names>L</given-names></name></person-group>
<article-title>Non-Hodgkin&#x02019;s lymphoma</article-title>. In: <person-group person-group-type="editor"><name name-style="western"><surname>Estlin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Gilbertson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Wynn</surname><given-names>RF</given-names></name></person-group> editors. <article-title>Pediatric Hematology and Oncology</article-title>. <year>2010</year> p. <fpage>109</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mbulaiteye</surname><given-names>SM</given-names></name><name name-style="western"><surname>Biggar</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Bhatia</surname><given-names>K</given-names></name><name name-style="western"><surname>Linet</surname><given-names>MS</given-names></name><name name-style="western"><surname>Devesa</surname><given-names>SS</given-names></name></person-group>
<article-title>Sporadic childhood Burkitt lymphoma incidence in the United States during 1992&#x02013;2005</article-title>. <source>Pediatr Blood Cancer</source>. <year>2009</year>
<month>9</month>; <volume>53</volume>(<issue>3</issue>): <fpage>366</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">19434731</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ladd</surname><given-names>AP</given-names></name><name name-style="western"><surname>Grosfeld</surname><given-names>JL</given-names></name></person-group>
<article-title>Gastrointestinal tumors in children and adolescents</article-title>. <source>Seminars in Pediatric surgery</source>. <year>2006</year>
<month>2</month>; <day>15</day>(<year>1</year>).</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quadri</surname><given-names>SK</given-names></name><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamdani</surname><given-names>NH</given-names></name><name name-style="western"><surname>Baba</surname><given-names>KM</given-names></name></person-group>
<article-title>Primary gastrointestinal lymphomas in children: an experience of 12 years from a tertiary care center of North India</article-title>. <source>Indian J Cancer</source>. <year>2016</year>; <volume>53</volume>: <fpage>300</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">28071632</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualco</surname><given-names>G</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>LM</given-names></name><name name-style="western"><surname>Harrington</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Bacchi</surname><given-names>CE</given-names><suffix>Jr</suffix></name>. </person-group>
<article-title>Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and C-Myc translocation in relation to clinical outcome</article-title>. <source>Am J Surg Pathol</source>. <year>2009</year>
<month>12</month>; <volume>33</volume>(<issue>12</issue>): <fpage>1815</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">19816150</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aledavood</surname><given-names>A</given-names></name><name name-style="western"><surname>Nasiri</surname><given-names>MRG</given-names></name><name name-style="western"><surname>Memar</surname><given-names>B</given-names></name><name name-style="western"><surname>Shahidsales</surname><given-names>S</given-names></name><name name-style="western"><surname>Raziee</surname><given-names>HR</given-names></name><name name-style="western"><surname>Ghafarzadegan</surname><given-names>K</given-names></name><etal>et al</etal>. </person-group>
<article-title>Primary gastrointestinal lymphoma</article-title>. <source>J Res Med Sci</source>. <year>2012</year>
<month>5</month>; <volume>17</volume>(<issue>5</issue>): <fpage>487</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">23626617</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghimire</surname><given-names>P</given-names></name><name name-style="western"><surname>Wu</surname><given-names>GY</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name></person-group>
<article-title>Primary gastrointestinal lymphoma</article-title>. <source>World J Gastroenterol</source>. <year>2011</year>
<month>2</month>
<day>14</day>; <volume>17</volume>(<issue>6</issue>): <fpage>697</fpage>&#x02013;<lpage>707</lpage>.<pub-id pub-id-type="pmid">21390139</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurzu</surname><given-names>S</given-names></name><name name-style="western"><surname>Bara</surname><given-names>T</given-names></name><name name-style="western"><surname>Bara</surname><given-names>T</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Turcu</surname><given-names>M</given-names></name><name name-style="western"><surname>Mardare</surname><given-names>CV</given-names></name><name name-style="western"><surname>Jung</surname><given-names>I</given-names></name></person-group>
<article-title>Gastric Burkitt lymphoma: a case report and literature review</article-title>. <source>Medicine (2017) 96: 49 (e8954)</source>. Article (PDF Available) in Medicine <volume>96</volume>(<issue>49</issue>): <fpage>e8954</fpage>
<month>12</month>
<year>2017</year>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JB</given-names></name><name name-style="western"><surname>Koo</surname><given-names>JS</given-names></name></person-group>
<article-title>Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>
<month>3</month>
<day>21</day>; <volume>20</volume>(<issue>11</issue>): <fpage>2751</fpage>&#x02013;<lpage>9</lpage>. Published online <year>2014</year>
<month>3</month>
<day>21</day>.<pub-id pub-id-type="pmid">24659867</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moschovi</surname><given-names>M</given-names></name><name name-style="western"><surname>Menegas</surname><given-names>D</given-names></name><name name-style="western"><surname>Stefanaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Van-Vliet Constantinidou</surname><given-names>C</given-names></name><name name-style="western"><surname>Tzortzatou-Stathopoulou</surname><given-names>F</given-names></name></person-group>
<article-title>Primary gastric Burkitt lymphoma in childhood: Associated with Helicobacter pylori</article-title>? <source>Med Pediatr Oncol</source>. <year>2003</year>; <volume>41</volume>(<issue>5</issue>): <fpage>444</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">14515383</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#x000fc;peli</surname><given-names>S</given-names></name><name name-style="western"><surname>Varan</surname><given-names>A</given-names></name><name name-style="western"><surname>Demir</surname><given-names>H</given-names></name><name name-style="western"><surname>Aydn</surname><given-names>B</given-names></name><name name-style="western"><surname>Y&#x000fc;ce</surname><given-names>A</given-names></name><name name-style="western"><surname>B&#x000fc;y&#x000fc;kpamuk&#x000e7;u</surname><given-names>M</given-names></name></person-group>
<article-title>Association of Helicobacter pylori and Childhood Lymphoma</article-title>. <source>J Pediatr Hematol Oncol</source>. <year>2007</year>
<month>5</month>; <volume>29</volume>(<issue>5</issue>): <fpage>301</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">17483706</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="book"><collab collab-type="authors">PDQ&#x000ae; Pediatric Treatment Editorial Board</collab>. <article-title>PDQ childhood non-Hodgkin lymphoma treatment</article-title>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Cancer Institute</publisher-name>
<comment>Updated 03/30/2018</comment> Available at: <ext-link ext-link-type="uri" xlink:href="http://www.cancer.gov/types/lymphoma/hp/child-nhl-treatment-pdq">https://www.cancer.gov/types/lymphoma/hp/child-nhl-treatment-pdq</ext-link>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bollard</surname><given-names>CM</given-names></name></person-group>
<article-title>Pediatric lymphomas and histiocytic disorders of childhood</article-title>. <source>Pediatr Clin North Am</source>. <year>2015</year>
<month>2</month>; <volume>62</volume>(<issue>1</issue>): <fpage>139</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">25435117</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanbar All</surname><given-names>H</given-names></name></person-group>
<article-title>Burkitt lymphoma and Burkitt-like lymphoma</article-title>. <source>Medscape Medical News</source>. Available at <ext-link ext-link-type="uri" xlink:href="http://emedicine.staging.medscape.com/article/1447602-overview">https://emedicine.staging.medscape.com/article/1447602-overview</ext-link>. Accessed <month>4</month>
<day>8</day>, <year>2016</year>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minard-Colin</surname><given-names>V</given-names></name><name name-style="western"><surname>Brugieres</surname><given-names>L</given-names></name><name name-style="western"><surname>Reiter</surname><given-names>A</given-names></name><name name-style="western"><surname>Cairo</surname><given-names>MS</given-names></name><name name-style="western"><surname>Gross</surname><given-names>TG</given-names></name><name name-style="western"><surname>Woessmann</surname><given-names>W</given-names></name><etal>et al</etal>. </person-group>
<article-title>Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead</article-title>. <source>Journal of Clinical Oncology</source>. <month>9</month>
<year>2015</year>; <volume>33</volume>(<issue>27</issue>): <fpage>2963</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">26304908</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burkhardt</surname><given-names>B</given-names></name><name name-style="western"><surname>Oschlies</surname><given-names>I</given-names></name><name name-style="western"><surname>Klapper</surname><given-names>W</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>M</given-names></name><name name-style="western"><surname>Woessmann</surname><given-names>W</given-names></name><name name-style="western"><surname>Meinhardt</surname><given-names>A</given-names></name><etal>et al</etal>. </person-group>
<article-title>Non-Hodgkin&#x02019;s lymphoma in adolescents: experiences in 378 adolescent NHL pateints treated according to pediatric NHL-BFM protocols</article-title>; <source>Leukemia</source>. <year>2011</year>; <volume>25</volume>: <fpage>153</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">21030984</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jourdain</surname><given-names>A</given-names></name><name name-style="western"><surname>Auperin</surname><given-names>A</given-names></name><name name-style="western"><surname>Minard-Colin</surname><given-names>V</given-names></name><name name-style="western"><surname>Aladjidi</surname><given-names>N</given-names></name><name name-style="western"><surname>Zsiros</surname><given-names>J</given-names></name><name name-style="western"><surname>Coze</surname><given-names>C</given-names></name><etal>et al</etal>. </person-group>
<article-title>Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective &#x0201c;Lymphomes Malins B&#x0201d; protocols</article-title>. <source>A Societe Francaise des Cancers de l&#x02019;Enfant study</source>. <publisher-name>Haematologica</publisher-name>
<year>2015</year>
<lpage>Jun</lpage>; <volume>100</volume>(<issue>6</issue>): <fpage>810</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Yue</surname><given-names>C</given-names></name></person-group>
<article-title>Gastrointestinal stromal tumor</article-title>. <source>J Gastrointest Oncol</source>. <year>2012</year>
<month>9</month>; <volume>3</volume>(<issue>3</issue>): <fpage>189</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="pmid">22943011</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janeway</surname><given-names>KA</given-names></name><name name-style="western"><surname>Weldon</surname><given-names>CB</given-names></name></person-group>
<article-title>Pediatric gastrointestinal stromal tumor</article-title>. <source>Seminars in pediatric surgery</source>. <year>2012</year>
<month>2</month>; <volume>21</volume>(<issue>1</issue>): <fpage>31</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">22248968</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishida</surname><given-names>T</given-names></name><name name-style="western"><surname>Blay</surname><given-names>JY</given-names></name><name name-style="western"><surname>Hirota</surname><given-names>S</given-names></name><name name-style="western"><surname>Kitagawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kang</surname><given-names>YK</given-names></name></person-group>
<article-title>The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines</article-title>. <source>Gastric Cancer</source>. <year>2016</year>; <volume>19</volume>(<issue>1</issue>); <fpage>3</fpage>&#x02013;<lpage>14</lpage>. Published online <year>2015</year>
<month>8</month>
<day>15</day> .<pub-id pub-id-type="pmid">26276366</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weldon</surname><given-names>CB</given-names></name><name name-style="western"><surname>Madenci</surname><given-names>AL</given-names></name><name name-style="western"><surname>Boikos</surname><given-names>SA</given-names></name><name name-style="western"><surname>Janeway</surname><given-names>KA</given-names></name><name name-style="western"><surname>George</surname><given-names>S</given-names></name><name name-style="western"><surname>Marget</surname><given-names>von Mehren</given-names></name><etal>et al</etal>. </person-group>
<article-title>Surgical management of Wild-type gastrointestinal stromal tumors: a report from National Institutes of Health Pediatric and Wildtype GIST Clinic</article-title>. <source>J Clin Oncol</source>. <year>2017</year>
<month>2</month>
<day>10</day>; <volume>35</volume>(<issue>5</issue>): <fpage>523</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">28029307</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ragelien&#x00117;</surname><given-names>L</given-names></name></person-group>
<article-title>Vaik&#x00173; hematologija.Vilnius: Vaist&#x00173; &#x0017e;inios</article-title>; <year>2002</year> p. <fpage>43</fpage>&#x02013;<lpage>84</lpage>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal">Available from: <ext-link ext-link-type="uri" xlink:href="http://intranet.tdmu.edu.ua/data/kafedra/internal/clinlab/classes_stud/en/med/lik/ptn/5/06.%20LABORATORY%20DIAGNOSTICS%20OF%20ANAEMIAS%20AND%20LEUKEMIAS%207.htm">http://intranet.tdmu.edu.ua/data/kafedra/internal/clinlab/classes_stud/en/med/lik/ptn/5/06.%20LABORATORY%20DIAGNOSTICS%20OF%20ANAEMIAS%20AND%20LEUKEMIAS%207.htm</ext-link></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reka</surname><given-names>G</given-names></name></person-group>
<article-title>Reticulocyte count and reticulocyte hemoglobin content</article-title>. Available at <ext-link ext-link-type="uri" xlink:href="http://emedicine.medscape.com/article/2086146-overview">https://emedicine.medscape.com/article/2086146-overview</ext-link>. Accessed <month>9</month>
<day>5</day>, <year>2014</year>.</mixed-citation></ref></ref-list></back></article>
